期刊文献+

卵巢癌二次探查手术前PET-CT检查的作用及临床意义 被引量:2

The clinical role of PET-CT examination before second look operation on patients with ovarian cancer
下载PDF
导出
摘要 目的探讨卵巢癌二次探查前行PET-CT检查的作用及临床意义。方法回顾性分析2006年2月-2010年12月手术治疗的、符合纳入标准的37例卵巢癌(16例行PET-CT检查)病历随访资料,比较二次探查术与PET-CT检查用于指导患者手术治疗随访结果。结果二次探查手术阳性率为67%;PET-CT检查阳性率为75%。PET-CT检查指导手术治疗组(S组)手术时间缩短,与直接二次探查手术组(对照组)相比,差异有统计学意义(P<0.01);S组中位生存时间较对照组延长(P<0.05);PET-CT检查组(T组即PET-CT检查后的手术及非手术病例)中位生存时间与行传统检查后直接行二次探查手术组相比,差异无统计学意义(P>0.05)。结论 PET-CT在二次探查手术前进行检查,可准确定位复发或转移部位,可缩短手术时间,延长术后患者生存期。但单纯以PET-CT结果为依据,判定患者是否需要二次手术,效果并不优于传统检查后行二次探查手术。 Objective To investigate the role of performance of integrated positron emission tomography and computed tomography(PET-CT) before second look operation(SLO) on patients with ovarian cancer.Methods The clinical data of 37 patients with ovarian cancer reached the admitted standard from February 2006 to December 2010 in our hospital were analyzed retrospectively,in which 16 patients were performed PET-CT.Results There were 67% patients with ovarian cancer in pathological diagnosis in SLO group(control group),and 75% in PET-CT performance group(T group).Compared with control group,less time was demanded during operation in the group of operation instructed by the results of PET-CT(S group)(P<0.01).Median survival time of S group was longer than that of control group.But there was no significant difference between control group and T group(P>0.05).Conclusion Performance of PET-CT before SLO on ovarian cancer could reduce operation time and prolong the survival time of patients with ovarian cancer.But the prognosis of operation instructed only by the results of PET-CT was not prior to SLO.
机构地区 解放军 解放军
出处 《东南国防医药》 2013年第2期141-143,共3页 Military Medical Journal of Southeast China
关键词 卵巢癌 二次探查手术 正电子发射断层-计算机断层扫描 ovarian cancer second look operation PET-CT
  • 相关文献

参考文献10

  • 1Salani R,Bristow RE. Surgical management of epithelial ovarian cancer[J].Clinical Obstetrics and Gynecology,2012,(01):75-95. 被引量:1
  • 2Suh DH,Kim K,Kim JW. Major clinical research advances in gynecologic cancer in 2011[J].J Gynecol Oncol,2012,(01):53-64. 被引量:1
  • 3邓云,任琼珍,胡建铭.先期化疗后Ki67指数在预测卵巢癌化疗敏感性中的作用[J].东南国防医药,2007,9(4):259-261. 被引量:1
  • 4Gungor M,Ortac F,Arras M. The role of secondary cytoreductive surgery for recurrent ovarian cancer[J].Gynecologic Oncology,2005,(01):74-79. 被引量:1
  • 5Schwarz JK,Grigsby PW,Dehdashti F. The role of 18F-FDG PET in assessing therapy response in cancer of the cervix and ovaries[J].Journal of Nuclear Medicine,2009,(Suppl 1):64-73. 被引量:1
  • 6Iyer VR,Lee SI. MRI,CT,and PET/CT for ovarian cancer detection and adnexal lesion characterization[J].American Journal of Roentgenology,2010,(02):311-321. 被引量:1
  • 7Picchio M,Sironi S,Messa C. Advanced ovarian carcinoma:usefulness of 18F-FDG-PET in combination with CT for lesion detection after primary treatment[J].Quarterly Journal of Nuclear Medicine,2003,(02):77-84. 被引量:1
  • 8赵军,管一晖,左传涛,华逢春,林祥通.^(18)F-FDG PET/CT在探测卵巢癌术后复发和转移中的价值[J].中国肿瘤,2007,16(3):187-189. 被引量:15
  • 9Thrall MM,DeLoia JA,Gallion H. Clinical use of combined positron emission tomography and computed tomography (FDGPET/CT) in recurrent ovarian cancer[J].Gynecologic Oncology,2007,(01):17-22. 被引量:1
  • 10Nanni C,Rubello D,Farsad M. 18F-FDG PET/CT in the evaluation of recurrent ovarian cancer:A prospective study on forty-one patients[J].European Journal of Surgical Oncology,2005,(07):792-797.doi:10.1016/j.ejso.2005.02.029. 被引量:1

二级参考文献12

  • 1赵军,林祥通.关于PET/CT临床应用的若干问题[J].中华核医学杂志,2005,25(2):69-71. 被引量:17
  • 2丁永为.实体瘤WHO疗效标准与对数杀灭定量评价的探讨[J].临床肿瘤学杂志,2005,10(4):384-387. 被引量:20
  • 3董孟杰,林祥通,赵军.PET-CT在卵巢癌中的临床应用价值[J].国外医学(放射医学核医学分册),2005,29(5):209-213. 被引量:7
  • 4Schroder W,Zimny M,Rudlowski U,et al.The role of 18F-fluoro-deoxyglucose positron emission tomography(^18F-FDG PET) in diagnosis of ovarian cancer[J].Int J Gynecol Cancer,1999,9(2):117-122. 被引量:1
  • 5Nakamoto Y,Saga T,Ishimori T,et al.Clinical value of positron emission tomography with FDG for recurrent ovarian cancer[J].AJR,2001,176(6):1449-1454. 被引量:1
  • 6Cho SM,Ha HK,Byun JY,et al.Usefulness of FDG PET for assessment of early recurrent epithelial ovarian cancer[J].AJR,2002,179(2):391-395. 被引量:1
  • 7Zhao J,Lin XT,Wu XH,et al.Detection of occult metastasis of recurrent ovarian cancer using integrated FDG PET/CT[J].J Nucl Med,2005,46(suppl 5):196P. 被引量:1
  • 8Makhija S,Howden N,Edwards R,et al.Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma:a retrospective review[J].Gynecol Oncol,2002,85(l):53-58. 被引量:1
  • 9Nanni C,Rubello D,Farsad M,et al.18F-FDG PET/CT in the evaluation of recurrent ovarian cancer:a prospective study on forty-one patients[J].Eur J Surg Oncol,2005,31(7):792-797. 被引量:1
  • 10Hauth EA,Antoch G,Stattaus J,et al.Evaluation of integrated whole-body PET/CT in the detection of recurrent ovarian cancer[J].Eur J Radiol,2005,56(2):263-268. 被引量:1

共引文献14

同被引文献28

  • 1李彦生,王俊起,刘磊,高硕.^(18)F—NaF的合成及其在肺癌骨转移中的临床应用[J].中华核医学杂志,2006,26(1):18-20. 被引量:8
  • 2王俊起,高硕.PET评价骨转移瘤[J].国际放射医学核医学杂志,2006,30(2):87-90. 被引量:6
  • 3Kruger S,Buck AK,Mottaghy FM,et al.Detection of bone metastases in patients with lung cancer:99mTc-MDP planar bone scintigraphy,18F-fluoride PET or18F-FDG PET/CT[J].Eur J Nucl Med Mol Imaging,2009,11(36):1807-1812. 被引量:1
  • 4Petersen H,Ogren M,Hoilund-Carlsen PF.Fluoride-positron emission tomography/computed tomography for differential diagnosis in suspected bone metastasis[J].Ugeskr Laeger,2010,172(20):1538-1539. 被引量:1
  • 5Aparici CM,Win AZ.Use of Na18F positron emission tomography/ computed tomography in the detection of bone metastasis from papillary renal cell carcinoma[J].World J Nucl Med,2014,13(2):135-137. 被引量:1
  • 6Tateishi U,Morita S,Taguri M,et al.A meta-analysis of18F-Fluoride positron emission tomography for assessment of metastatic bone tumor[J].Ann Nucl Med,2010,24(7):523-531. 被引量:1
  • 7Lim R,Fahey FH,Drubach LA,et al.Early experience with 18fluorine sodium fluoride bone PET in young patients with back pain[J].J Pediatr Orthop,2007,27(3):277-282. 被引量:1
  • 8Blake GM,Park-Holohan S J,Cook GJ,et al.Quantitative studies of bone with the use of 18F-fluoride and 99Tcm-methylene diphosphonate[J].SeminNucl Med,2001,31(11):28-49. 被引量:1
  • 9Ullmark G,Sorensen J,Nilsson O,et al.Analysis of bone formation on porous and calcium phosphate-coated acetabular cups:a randomized clinical 18fluoride study[J].Hip Int,2012,22(2):172-178. 被引量:1
  • 10Yen RF,Chen CY,Cheng MF,et al.The diagnostic and prognostic effectiveness of 18F sodium fluoride PET-CT in detecting bone metastases for hepatocellular carcinoma patients[J].Nucl Med Commun,2010,31(7):637-645. 被引量:1

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部